Image-Guided Sentinel Lymph Node Mapping and Nanotechnology-Based Nodal Treatment in Lung Cancer Using Invisible Near-Infrared Fluorescent Light

Seminars in Thoracic and Cardiovascular Surgery

Volumn 21, Issue 4, 2009, Pages 309-315

  Khullar, Onkar ^a   Frangioni, John V ^b   Grinstaff, Mark ^c   Colson, Yolonda Lorig ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c BOSTON UNIVERSITY   (United States)

Author keywords

nanoparticle; nanotechnology; near infrared; sentinel lymph node mapping

Indexed keywords

INDOCYANINE GREEN; NANOPARTICLE; PACLITAXEL; POLYMER; QUANTUM DOT;

ARTICLE; AUTOFLUORESCENCE IMAGING; BREAST CANCER; CANCER RECURRENCE; CANCER RISK; HUMAN; LOW DRUG DOSE; LUNG CANCER; LUNG PARENCHYMA; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM EXAMINATION; LYMPHOSCINTIGRAPHY; MICROMETASTASIS; NANOIMAGING; NANOTECHNOLOGY; NONHUMAN; REGIONAL METASTASIS; SENTINEL LYMPH NODE; SENTINEL LYMPH NODE MAPPING; STOMACH CANCER;

ANIMALS; DIAGNOSTIC IMAGING; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; FLUORESCENCE; FLUORESCENT DYES; HUMANS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; NANOPARTICLES; NANOTECHNOLOGY; PREDICTIVE VALUE OF TESTS; QUANTUM DOTS; SPECTROSCOPY, NEAR-INFRARED; TREATMENT OUTCOME;

EID: 77649246204     PISSN: 10430679     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semtcvs.2009.11.009     Document Type: Article

References (60)

1. Jakub J.W., Pendas S., and Reintgen D.S. Current status of sentinel lymph node mapping and biopsy: Facts and controversies. Oncologist 8 (2003) 59-68
2. Chen S.L., Iddings D.M., Scheri R.P., et al. Lymphatic mapping and sentinel node analysis: Current concepts and applications. CA Cancer J Clin 56 (2006) 292-309
3. Morton D.L., Thompson J.F., Cochran A.J., et al. Sentinel-node biopsy or nodal observation in melanoma. N Engl J Med 355 (2006) 1307-1317
4. Liptay M.J. Sentinel node mapping in lung cancer: The Holy Grail?. Ann Thorac Surg 85 (2008) S778-S779
5. Little A.G., DeHoyos A., Kirgan D.M., et al. Intraoperative lymphatic mapping for non-small cell lung cancer: The sentinel node technique. J Thorac Cardiovasc Surg 117 (1999) 220-224
6. Schmidt F.E., Woltering E.A., Webb W.R., et al. Sentinel nodal assessment in patients with carcinoma of the lung. Ann Thorac Surg 74 (2002) 870-874 discussion 4-5
7. Sugi K., Fukuda M., Nakamura H., et al. Comparison of three tracers for detecting sentinel lymph nodes in patients with clinical N0 lung cancer. Lung Cancer 39 (2003) 37-40
8. Nomori H., Ikeda K., Mori T., et al. Sentinel node navigation segmentectomy for clinical stage IA non-small cell lung cancer. J Thorac Cardiovasc Surg 133 (2007) 780-785
9. Liptay M.J., D'Amico T.A., Nwogu C., et al. Intraoperative sentinel node mapping with technitium-99 in lung cancer: Results of CALGB 140203 multicenter phase II trial. J Thorac Oncol 4 (2009) 198-202
10. Liptay M.J., Masters G.A., Winchester D.J., et al. Intraoperative radioisotope sentinel lymph node mapping in non-small cell lung cancer. Ann Thorac Surg 70 (2000) 384-389 discussion 389-390
11. Liptay M.J. Sentinel node mapping in lung cancer. Ann Surg Oncol 11 (2004) 271S-274S
12. Chance B. Near-infrared images using continuous, phase-modulated, and pulsed light with quantitation of blood and blood oxygenation. Ann N Y Acad Sci 838 (1998) 29-45
13. Weissleder R. A clearer vision for in vivo imaging. Nat Biotechnol 19 (2001) 316-317
14. Frangioni J.V. In vivo near-infrared fluorescence imaging. Curr Opin Chem Biol 7 (2003) 626-634
15. Lim Y.T., Kim S., Nakayama A., et al. Selection of quantum dot wavelengths for biomedical assays and imaging. Mol Imaging 2 (2003) 50-64
16. Conway J.M., Norris K.H., and Bodwell C.E. A new approach for the estimation of body composition: Infrared interactance. Am J Clin Nutr 40 (1984) 1123-1130
17. Sevick-Muraca E.M., Houston J.P., and Gurfinkel M. Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents. Curr Opin Chem Biol 6 (2002) 642-650
18. Frangioni J.V. New technologies for human cancer imaging. J Clin Oncol 26 (2008) 4012-4021
19. Rasmussen J.C., Tan I.C., Marshall M.V., et al. Lymphatic imaging in humans with near-infrared fluorescence. Curr Opin Biotechnol 20 (2009) 74-82
20. Reuthebuch O., Häussler A., Genoni M., et al. Novadaq SPY: Intraoperative quality assessment in off-pump coronary artery bypass grafting. Chest 125 (2004) 418-424
21. Sekijima M., Tojimbara T., Sato S., et al. An intraoperative fluorescent imaging system in organ transplantation. Transplant Proc 36 (2004) 2188-2190
22. Gioux S., Kianzad V., Ciocan R., et al. High-power, computer-controlled, light-emitting diode-based light sources for fluorescence imaging and image-guided surgery. Mol Imaging 8 (2009) 156-165
23. ™ intraoperative near-infrared fluorescence imaging system: A first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol 16 (2009) 2943-2952
24. Swart P.J., Beljaars L., Kuipers M.E., et al. Homing of negatively charged albumins to the lymphatic system: General implications for drug targeting to peripheral tissues and viral reservoirs. Biochem Pharmacol 58 (1999) 1425-1435
25. Josephson L., Mahmood U., Wunderbaldinger P., et al. Pan and sentinel lymph node visualization using a near-infrared fluorescent probe. Mol Imaging 2 (2003) 18-23
26. Ohnishi S., Lomnes S.J., Laurence R.G., et al. Organic alternatives to quantum dots for intraoperative near-infrared fluorescent sentinel lymph node mapping. Mol Imaging 4 (2005) 172-181
27. Frangioni J.V., Kim S.W., Ohnishi S., et al. Sentinel lymph node mapping with type-II quantum dots. Methods Mol Biol 374 (2007) 147-159
28. Hauck T.S., Anderson R.E., Fischer H.C., et al. In vivo quantum-dot toxicity assessment. Small 6 (2010) 138-144
29. Soltesz E.G., Kim S., Laurence R.G., et al. Intraoperative sentinel lymph node mapping of the lung using near-infrared fluorescent quantum dots. Ann Thorac Surg 79 (2005) 269-277 discussion 269-277
30. Parungo C.P., Colson Y.L., Kim S.W., et al. Sentinel lymph node mapping of the pleural space. Chest 127 (2005) 1799-1804
31. Parungo C.P., Ohnishi S., Kim S.W., et al. Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging. J Thorac Cardiovasc Surg 129 (2005) 844-850
32. Kim S., Lim Y.T., Soltesz E.G., et al. Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 22 (2004) 93-97
33. Soltesz E.G., Kim S., Kim S.W., et al. Sentinel lymph node mapping of the gastrointestinal tract by using invisible light. Ann Surg Oncol 13 (2006) 386-396
34. Parungo C.P., Soybel D.I., Colson Y.L., et al. Lymphatic drainage of the peritoneal space: A pattern dependent on bowel lymphatics. Ann Surg Oncol 14 (2007) 286-298
35. Knapp D.W., Adams L.G., Degrand A.M., et al. Sentinel lymph node mapping of invasive urinary bladder cancer in animal models using invisible light. Eur Urol 52 (2007) 1700-1708
36. Ballou B., Ernst L.A., Andreko S., et al. Imaging vasculature and lymphatic flow in mice using quantum dots. Methods Mol Biol 574 (2009) 63-74
37. Tanaka E., Choi H.S., Fujii H., et al. Image-guided oncologic surgery using invisible light: Completed pre-clinical development for sentinel lymph node mapping. Ann Surg Oncol 13 (2006) 1671-1681
38. Reynolds J.S., Troy T.L., Mayer R.H., et al. Imaging of spontaneous canine mammary tumors using fluorescent contrast agents. Photochem Photobiol 70 (1999) 87-94
39. Kwon S., and Sevick-Muraca E.M. Noninvasive quantitative imaging of lymph function in mice. Lymphat Res Biol 5 (2007) 219-231
40. Ogata F., Azuma R., Kikuchi M., et al. Novel lymphography using indocyanine green dye for near-infrared fluorescence labeling. Ann Plast Surg 58 (2007) 652-655
41. Kitai T., Inomoto T., Miwa M., et al. Fluorescence navigation with indocyanine green for detecting sentinel lymph nodes in breast cancer. Breast Cancer 12 (2005) 211-215
42. Ogasawara Y., Ikeda H., Takahashi M., et al. Evaluation of breast lymphatic pathways with indocyanine green fluorescence imaging in patients with breast cancer. World J Surg 32 (2008) 1924-1929
43. Sevick-Muraca E.M., Sharma R., Rasmussen J.C., et al. Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: Feasibility study. Radiology 246 (2008) 734-741
44. Miyashiro I., Miyoshi N., Hiratsuka M., et al. Detection of sentinel node in gastric cancer surgery by indocyanine green fluorescence imaging: Comparison with infrared imaging. Ann Surg Oncol 15 (2008) 1640-1643
45. Tajima Y., Yamazaki K., Masuda Y., et al. Sentinel node mapping guided by indocyanine green fluorescence imaging in gastric cancer. Ann Surg 249 (2009) 58-62
46. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 6 (2006) 688-701
47. Torchilin V.P. Multifunctional nanocarriers. Adv Drug Deliv Rev 58 (2006) 1532-1555
48. Kabanov A.V. Polymer genomics: An insight into pharmacology and toxicology of nanomedicines. Adv Drug Deliv Rev 58 (2006) 1597-1621
49. Davis M.E., Chen Z.G., and Shin D.M. Nanoparticle therapeutics: An emerging treatment modality for cancer. Nat Rev Drug Discov 7 (2008) 771-782
50. Chen J., Wang L., Yao Q., et al. Drug concentrations in axillary lymph nodes after lymphatic chemotherapy on patients with breast cancer. Breast Cancer Res 6 (2004) R474-R477
51. Xie Y., Bagby T.R., Cohen M., et al. Drug delivery to the lymphatic system: Importance in future cancer diagnosis and therapies. Expert Opin Drug Deliv 6 (2009) 785-792
52. Nishioka Y., and Yoshino H. Lymphatic targeting with nanoparticulate system. Adv Drug Deliv Rev 47 (2001) 55-64
53. Moghimi S.M., Hawley A.E., Christy N.M., et al. Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes. FEBS Lett 344 (1994) 25-30
54. Hawley A.E., Illum L., and Davis S.S. Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm Res 14 (1997) 657-661
55. Reddy S.T., Rehor A., Schmoekel H.G., et al. In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles. J Control Release 112 (2006) 26-34
56. Liu J., Meisner D., Kwong E., et al. A novel trans-lymphatic drug delivery system: Implantable gelatin sponge impregnated with PLGA-paclitaxel microspheres. Biomaterials 28 (2007) 3236-3244
57. Liu J., Meisner D., Kwong E., et al. Translymphatic chemotherapy by intrapleural placement of gelatin sponge containing biodegradable paclitaxel colloids controls lymphatic metastasis in lung cancer. Cancer Res 69 (2009) 1174-1181
58. Lu H.X., Li B., Kang Y., et al. Paclitaxel nanoparticle inhibits growth of ovarian cancer xenografts and enhances lymphatic targeting. Cancer Chemother Pharmacol 59 (2007) 175-181
59. Griset A.P., Walpole J., Liu R., et al. Expansile nanoparticles: Synthesis, characterization, and in vivo efficacy of an acid-responsive drug delivery system. J Am Chem Soc 131 (2009) 2469-2471
60. Farokhzad O.C., and Langer R. Impact of nanotechnology on drug delivery. ACS Nano 3 (2009) 16-20